Old Web
English
Sign In
Acemap
>
authorDetail
>
Jonathan Glass
Jonathan Glass
LSU Health Sciences Center New Orleans
Immunology
Medicine
Internal medicine
Ferritin
Myeloid leukemia
6
Papers
32
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Commercial Insurance Triples Chances of Breast Cancer Survival in a Public Hospital
2013
Breast Journal
Runhua Shi
Glenn Mills
Jerry McLarty
Gary Burton
Zhenzhen Shi
Jonathan Glass
Show All
Source
Cite
Save
Citations (15)
Anticancer activity of the iron facilitator LS081
2011
Journal of Experimental & Clinical Cancer Research
Zhen Li
Hiroki Tanaka
Floyd Galiano
Jonathan Glass
Show All
Source
Cite
Save
Citations (9)
A Randomized Phase II Study Evaluating the Efficacy and Safety of Deferasirox Versus Deferoxamine in Patients with Sickle Cell Disease (SCD): 2-Year Results Including Pharmacokinetics (PK) and Safety of Deferasirox with Concomitant Hydroxyurea Therapy
2011
Blood
Elliott Vichinsky
Marcela Torres
Jonathan Glass
Caterina P. Minniti
Stéphane Barrette
Dany Habr
Nicola Lynch
Yiyun Zhang
Beatrice Files
Show All
Source
Cite
Save
Citations (2)
Troglitazone Exerts a Cell-Dependent Effect on the Extracellular Secretion of VEGF 165 Independently from the Rapamycin Sensitivity or the Level of eIF4E Expression in AML-Derived Cells.
2004
Blood
Ellen Friday
Jonathan Glass
Francesco Turturro
Show All
Source
Cite
Save
Citations (0)
1